In vivo electrochemical measurement of the long-lasting release of dopamine and serotonin induced by intrastriatal kainic acid

Journal of Neurochemistry

Volumn 69, Issue 5, 1997, Pages 2039-2047

  Nakazato, Taizo ^a   Akiyama, Akitane ^b  

^a JUNTENDO UNIVERSITY   (Japan)

^b TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Cell death; Excitatory amino acid; GABA; Huntington's disease; In vivo voltammetry; Monoamine release

Indexed keywords

4 AMINOBUTYRIC ACID; DOPAMINE; EXCITATORY AMINO ACID; KAINIC ACID; MONOAMINE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; HUNTINGTON CHOREA; MALE; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NONHUMAN; POTENTIOMETRY; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; SEROTONINERGIC NERVE CELL; SYNAPTOSOME;

ANIMALIA;

EID: 0030800673     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.69052039.x     Document Type: Article

References (43)

1. Akiyama A., Kalo T., Ishii K., and Yasuda E. (1985) In vitro measurement of dopamine concentration with carbon fiber electrode. Anal. Chem. 57, 1518-1522.
2. Bonhomme V., Hans P., Collette J., and Moonen G. (1993) Neuron-specific enolase as a marker of in vitro neuronal damage. Part II: Investigation of the astrocyte protective effect against kainate-induced neurotoxicity. J. Neurosurg. Anesthesiol. 5, 117-120.
3. Braszko J. J., Bannon M. J., Bunney B. S., and Roth R. H. (1981) Intrastriatal kainic acid: acute effects on electrophysiological and biochemical measures of nigro-striatal dopaminergic activity. J. Pharmacol. Exp. Ther. 216, 289-293.
4. Brownstein M. J. (1981) Serotonin, histamine, and the purines, in Basic Neurochemistry (Siegel G. J., Albers R. W., Agranoff B. W., and Katzman R., eds), pp. 27-36. Little, Brown, Boston.
5. Bruyn G. W. and Went L. N. (1986) Huntington's chorea, in Handbook of Clinical Neurology, Vol. 5 (49): Extrapyramidal Disorders (Vinken P. J., Bruyn G. W., and Klawans H. L., eds), pp. 267-313. Elsevier, Amsterdam.
6. Carter C. J., L'Heureux R., and Scatton B. (1988) Differentia control by N-methyl-D-aspartate and kainate of striatal dopamine release in vivo: a trans-striatal dialysis study. J. Neurochem. 51, 462-468.
7. Chéramy A., Romo R., Godeheu G., Baruch P., and Glowinski J. (1986) In vivo presynaptic control of dopamine release in the cat caudate nucleus. II: Facilitatory or inhibitory influence of L-glutamate. Neuroscience 19, 1081-1090.
8. Coyle J. T. and Schwarcz R. (1976) Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea. Nature 263, 244-246.
9. Coyle J. T. and Schwarcz R. (1983) The use of excitatory amino acids as selective neurotoxins, in Handbook of Chemical Neuroanatomy, Vol. 1 (Björklund A. and Hökfelt T., eds), pp. 508-527. Elsevier, Amsterdam.
10. Coyle J. T., Molliver M. E., and Kuhar M. J. (1978) In situ injection of kainic acid: a new method for selectively lesioning neuronal cell bodies while sparing axons of passage. J. Comp. Neurol. 180, 301-324.
11. Frankhuyzen A. L. and Mulder A. H. (1977) Release of radiolabeled dopamine, serotonin, acetylcholine and GABA from slices of rat striatum after intrastriatal kainic acid injections. Brain Res. 135, 368-373.
12. Giorguieff M. F., Kernel M. L., and Glowinski J. (1977) Presynaptic effect of L-glutamic acid on the release of dopamine in the rat striatal slices. Neurosci. Lett. 6, 73-77.
13. Hattori T. and McGeer E. G. (1977) Fine structural changes in the rat striatum after local injections of kainic acid. Brain Res. 129, 174-180.
14. Kabuto H., Yokoi I., Mizukawa K., and Mori A. (1989) Effects of an N-methyl-D-aspartate receptor agonist and its antagonist CPP on the levels of dopamine and serotonin metabolites in rat striatum collected in vivo by using a brain dialysis technique. Neurochem. Res. 14, 1075-1080.
15. Keihoff G. and Wolf G. (1993) Comparison of double fluorescence staining and LDH-test for monitoring cell viability in vitro. Neuroreport 5, 129-132.
16. Kikuchi S. and Kim S. U. (1993) Glutamate neurotoxicity in mesencephalic dopaminergic neurons in culture. J. Neurosci. Res 36, 558-569.
17. Koe B. K. and Weissman A. (1966) p-Chlorophenylalanine: a specific depletor of brain serotonin. J. Pharmacol. Exp. Ther. 154, 499-516.
18. Krebs M. O., Desce J. M., Kernel M. L., Gauchy C. Godeheu G., Chéramy A., and Glowinski J. (1991) Glutamatergic control of dopamine release in the rat striatum: evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals. J. Neurochem. 56, 81-85.
19. Leviel V., Gobert A., and Guibert B. (1990) The glutamate-mediated release of dopamine in the rat striatum: further characterization of the dual excitatory-inhibitory function. Neuroscience 39, 305-312.
20. McGeer P. L. and McGeer E. G. (1975) Evidence for glutamic acid decarboxylase interneurons in the neostriatum. Brain Res. 91, 331-335.
21. Mugnaini E. and Oertel W. H. (1985) An atlas of the distribution of GABAergic neurons and terminals in the rat CNS as revealed by GAD immunohistochemistry, in Handbook of Chemical Neuroanatomy, Vol. 4 (Björklund A. and Hökfelt T., eds), pp. 436-608. Elsevier, Amsterdam.
22. Nakazato T. and Akiyama A. (1988a) Microcomputer-controlled in vivo voltammetry. Biog. Amines 5, 339-350.
23. Nakazato T. and Akiyama A. (1988b) In vivo voltammetric study of 6-hydroxydopamine-induced neuronal degradation. J. Neurochem. 51, 1007-1013.
24. Nakazato T. and Akiyama A. (1989) Effect of exogenous L-DOPA on behavior in the rat: an in vivo voltammetric study. Brain Res. 490, 332-338.
25. Nakazato T. and Akiyama A. (1992) Decarboxylation of exogenous L-3,4-dihydroxyphenylalanine in rat striatum as studied by in vivo voltammetry. J. Neurochem. 58, 121-127.
26. Nakazato T. and Akiyama A. (1998) Immediate and long-term effects of 5,7-dihydroxytryptamine on rat striatal serotonergic neurons measured using in vivo voltammetry. Neurochem. Res. 23, 1-6.
27. Nakazato T., Hosoda S., and Akiyama A. (1993) A triangular conditioning voltage wave does not influence spontaneous neuronal activity in the rat striatum. J. Neurosci. Methods 46, 69-72.
28. Naudon L., Dourmap N., Leroux-Nicollet I., and Costentin J. (1992a) Kainic acid lesion of the striatum increases dopamine release but reduces 3-methoxytyramine level. Brain Res. 572, 247-249.
29. Naudon L., Leroux-Nicollet I., and Costentin J. (1992b) Consequences of an intrastriatal injection of kainic acid on the dopaminergic neuronal and vesicular uptake systems. Brain Res. 593, 32-38.
30. Olney J. W., Rhee V., and Ho O. L. (1974) Kainic acid: a powerful neurotoxin analogue of glutamate. Brain Res. 77, 507-512.
31. Paxinos G. and Watson C. (1982) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
32. Reid M. S., Herrera-Marschitz M., Hökfelt T., Lindefors N., Persson H., and Ungerstedt U. (1990) Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of nigrostriatal dopamine release: evidence for direct regulatory mechanisms. Exp. Brain Res. 82, 293-303.
33. 3H] dopamine release from rat striatum: in vitro model for glutamate actions. J. Neurochem. 32, 1539-1545.
34. Rothman S. M., Thurston J. H., and Hauhart R. E. (1987) Delayed neurotoxicity of excitatory amino acids in vitro. Neuroscience 22, 471-480.
35. Ruzicka B. B. and Jhamandas K. (1991) Met-enkephalin release from slices of the rat striatum and globus pallidus: stimulation by excitatory amino acids. J. Pharmacol. Exp. Ther. 257, 1025-1033.
36. Samanin R., Quattrone A., Peri G., Ladinsky H., and Consolo S. (1978) Evidence of an interaction between serotonergic and cholinergic neurons in the corpus striatum and hippocampus of the rat brain. Brain Res. 151, 73-82.
37. Schwarcz R. and Coyle J. T. (1977) Striatal lesions with kainic acid: neurochemical characteristics. Brain Res. 127, 235-249.
38. Spector S. (1966) Inhibitors of endogenous catecholamine biosynthesis. Pharmacol. Rev. 18, 599-609.
39. Sperk G., Berger M., Hörtnagl H., and Horneykiewicz O. (1981) Kainic acid-induced changes of serotonin and dopamine metabolism in the striatum and substantia nigra of the rat. Eur. J. Pharmacol. 74, 279-286.
40. Westerink B. H. C., Santiago M., and De Vries J. B. (1992) The release of dopamine from nerve terminals and dendrites of nigrostriatal neurons induced by excitatory amino acids in the conscious rat. Naunyn Schmiedebergs Arch. Pharmacol. 345, 523-529.
41. Wright J. M. and Nowak L. M. (1992) Effect of low doses of bicuculline on N-methyl-D-aspartate single-channel kinetics are not evident in whole-cell currents. Mol. Pharmacol. 41, 900-907.
42. Young A. M. J. and Bradford H. F. (1993) N-Methyl-D-aspartate releases γ-aminobutyric acid from rat striatum in vivo: a microdialysis study using a novel preloading method. J. Neurochem. 60, 489-492.
43. Young A. M. J.,CrowderJ. M., and Bradford H. F. (1988) Potentiation by kainate of excitatory amino acid release in striatum: complementary in vivo and in vitro experiments. J. Neurochem. 50, 337-345.